ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,828Medicare Part D Prescriptions Filled, Including Refills

Rank: 112 out of 973

$513K Total Retail Price of All Prescriptions

Rank: 140 out of 973

338 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 338 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 338 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 9,159 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 804 735 1 2
POTASSIUM CHLORIDE 377 332 2 9
OMEPRAZOLE 339 268 3 5
SIMVASTATIN 313 260 4 1
FUROSEMIDE 311 288 5 6
AMLODIPINE BESYLATE 284 267 6 7
HYDROCODONE-ACETAMINOPHEN 250 214 S3 7 4
MELOXICAM 249 230 8 23
LISINOPRIL 238 206 9 3
METFORMIN HCL 203 174 10 8
GABAPENTIN 193 106 11 12
WARFARIN SODIUM 181 176 12 10
COUMADIN 171 171 13 205
SPIRONOLACTONE 154 153 14 49
ZOLPIDEM TARTRATE 154 131 14 20
METOPROLOL SUCCINATE 147 116 16 17
LOSARTAN POTASSIUM 143 143 17 19
LOSARTAN-HYDROCHLOROTHIAZIDE 137 112 18 46
HYDROCHLOROTHIAZIDE 130 113 19 11
METOPROLOL TARTRATE 124 110 20 13
CITALOPRAM HBR 120 110 21 14
CEPHALEXIN 117 106 22 75
NEXIUM 110 54 23 30
LOVASTATIN 108 96 24 38
DIGOXIN 107 107 25 32
ATENOLOL 104 94 26 16
ATORVASTATIN CALCIUM 97 86 27 15
LANTUS 95 76 28 39
MIRTAZAPINE 93 64 29 43
AMITRIPTYLINE HCL 91 81 R 30 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 91 30 25
PRAVASTATIN SODIUM 90 73 32 22
TAMSULOSIN HCL 85 74 33 28
ALLOPURINOL 84 83 34 29
POLYETHYLENE GLYCOL 3350 80 59 35 36
CLOPIDOGREL 77 56 36 44
DONEPEZIL HCL 77 77 36 26
FLUOXETINE HCL 72 65 38 56
GLYBURIDE 72 66 R 38 59
SERTRALINE HCL 71 65 40 21
TRAZODONE HCL 70 57 41 48
AMLODIPINE BESYLATE-BENAZEPRIL 67 67 42 80
PREDNISONE 67 67 42 33
EXELON 64 64 44 117
CIPROFLOXACIN HCL 62 60 45 57
ALENDRONATE SODIUM 58 58 46 24
GEMFIBROZIL 57 45 47 83
FENTANYL 56 48 S2 48 53
CYMBALTA 55 38 49 40
AZITHROMYCIN 54 43 50 47
CLONIDINE HCL 52 39 51 67
VERAPAMIL ER 51 51 52 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.